Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02967068 · ClinicalTrials.gov registry record

VCRC Tissue Repository

A clinical trial of Giant Cell Arteritis and IgA Vasculitis, sponsored by University of Pennsylvania.

Recruiting
Registry status
1,000
Enrollment target
8
Study locations

NCT02967068 is a study of Giant Cell Arteritis and IgA Vasculitis that is actively recruiting participants, run by University of Pennsylvania. The registered enrollment target is 1,000 participants, above the 907-participant average among 7 other Giant Cell Arteritis trials with a reported enrollment target (10% higher). The trial reports 8 study locations across 5 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02967068, a study of Giant Cell Arteritis and IgA Vasculitis, is actively recruiting participants, sponsored by University of Pennsylvania.

RECRUITING
Registry status
1,000 participants
Enrollment target
8
Study locations

Study Summary

The purpose of this study is to collect existing tissue specimens from subjects enrolled in Vasculitis Clinical Research Consortium (VCRC) studies. Analysis of these tissue specimens and linked clinical data collected through VCRC studies may lead to the identification and development of a series of translational research projects. Results of these studies will provide vasculitis researchers with insight into the causes of these diseases and generate new ideas for diagnostic tests and therapies, and will be of great interest to the larger communities of researchers investigating vasculitis and other autoimmune, inflammatory, and vascular diseases.

Conditions Studied

Giant Cell Arteritis IgA Vasculitis Microscopic Polyangiitis Eosinophilic Granulomatosis With Polyangiitis Polyarteritis Nodosa Granulomatosis With Polyangiitis (Wegener's) Aortitis Cutaneous Vasculitis Henoch-Schonlein Purpura Takayasu Arteritis

Study Locations (8)

Massachusetts

  • Brigham and Women's Hospital - Boston
  • Boston University School of Medicine - Boston

Pennsylvania

  • University of Pennsylvania - Philadelphia
  • University of Pittsburgh - Pittsburgh

Ontario

  • St. Joseph's Healthcare - Hamilton
  • University of Toronto Mount Sinai Hospital - Toronto

Ohio

  • Cleveland Clinic - Cleveland

Utah

  • University of Utah - Salt Lake City

Trial Details

FieldValue
Enrollment Target 1,000 participants
Start Date 2016-11
Est. Completion 2028-12

Sponsor

University of Pennsylvania

1,423 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02967068

The ClinicalTrials.gov registry entry for NCT02967068 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 1,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 907-participant average among 7 other Giant Cell Arteritis trials with a reported enrollment target (10% higher). The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.

The record links to 10 conditions, with Giant Cell Arteritis appearing as the primary indexed condition, and to 0 interventions.

NCT02967068 reports 8 study locations spanning 5 distinct geographic areas - top geographies include Massachusetts, Pennsylvania, Ontario.

Frequently Asked Questions

What is clinical trial NCT02967068 about?

NCT02967068 is a clinical study titled "VCRC Tissue Repository". The purpose of this study is to collect existing tissue specimens from subjects enrolled in Vasculitis Clinical Research Consortium (VCRC) studies. Analysis of these tissue specimens and linked clinical data collected through VCRC studies may lead to the identification and development of a series of...

What is the current status of trial NCT02967068?

This trial is currently recruiting. The enrollment target is 1,000 participants. The study started on 2016-11. Estimated completion is 2028-12.

What conditions does trial NCT02967068 study?

This clinical trial studies the following conditions: Giant Cell Arteritis, IgA Vasculitis, Microscopic Polyangiitis, Eosinophilic Granulomatosis With Polyangiitis, Polyarteritis Nodosa.

Who is sponsoring clinical trial NCT02967068?

This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02967068 being conducted?

This trial has 8 study locations across Massachusetts, Ohio, Pennsylvania, Utah, Ontario. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Giant Cell Arteritis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Giant Cell Arteritis

All registered trials for this condition

IgA Vasculitis

All registered trials for this condition

Massachusetts

All trials with a study site in Massachusetts

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.